NCT05709938View on ClinicalTrials.gov

Comparison of Insulin Glargine and Regular Insulin Versus NPH and Regular Insulin in the Treatment of T1DM

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

January 5, 2021

Study Completion Date

April 20, 2021

Conditions

To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children

Interventions

DRUG

Glargine and regular insulin versus NPH and regular insulin

"Patients with type 1 diabetes (T1DM) in group A received insulin glargine as basal therapy at night and regular insulin given prior to each main meal.~Patients in group B were given NPH and regular insulin in split and mix method in the morning and evening."

Trial Locations (1)

54000

Pediatric endocrine and diabetes section, Pediatric department, Mayo Hospital, Lahore

All Listed Sponsors

lead

King Edward Medical University

OTHER

NCT05709938 - Comparison of Insulin Glargine and Regular Insulin Versus NPH and Regular Insulin in the Treatment of T1DM | Biotech Hunter | Biotech Hunter